Lumov

Lumov, based in India, offers orthopedic and mobility solutions designed to alleviate pain, specifically catering to the unique needs of Indian body types and conditions. Lumov specializes in providing orthopedic and mobility solutions. Founded in 2024, the company is headquartered in Bangalore, India. It has successfully completed one deal, culminating in a Seed funding round of USD 1.

2 million on December 9, 2025, led by Incubate Fund with contributions from IIMA Ventures, QRG Investments and Holdings, and SIDBI. The founder's background or prior ventures are not detailed. Lumov Health specializes in clinically superior products designed to alleviate pain and enhance mobility for users, particularly focusing on Indian body types and conditions. Their core offerings include a comprehensive range of orthotic solutions, rehabilitation aids, and wellness products aimed at effective pain management.

Notable products include the Wrist Brace Prime, Lumbo Sacral Belt Ultima, and various knee and elbow braces, all developed with high-quality materials and backed by recent scientific research. These products serve a diverse clientele, including individuals experiencing chronic pain and professionals requiring reliable support during daily activities. Lumov Health products are primarily targeted at the Indian market, addressing the needs of over 300 million people affected by body pain, allowing them to regain functionality in their daily routines. Revenue generation for Lumov Health stems from direct-to-consumer sales and partnerships with healthcare professionals and retailers.

Transactions are facilitated through an e-commerce platform, where consumers can purchase products individually, such as the flagship Lumbo Sacral Belt Ultima or the Wrist Brace Prime. The company engages in business-to-business collaborations with physiotherapists and clinics, providing specialized products tailored to their patient needs. This multifaceted approach allows Lumov Health to cater to various market segments while ensuring their products are accessible to a broad audience. In December 2025, Lumov raised USD 1.

2 million in Seed funding led by Incubate Fund, which will be utilized to enhance product development and expand market reach. The company plans to launch new products tailored for pain management and aims to enter additional markets in Southeast Asia by the end of 2026, targeting a broader customer base that includes individuals suffering from orthopedic issues.